Premium
P2‐644: SAFETY, TOLERABILITY, AND LIFESTYLE CHANGES ASSOCIATED WITH APOE DISCLOSURE IN THE BUTLER ALZHEIMER'S PREVENTION REGISTRY: IMPLICATIONS FOR RECRUITMENT TO CLINICAL TRIALS
Author(s) -
Alber Jessica,
Collier Meghan K.,
Goldfarb Danielle,
Thompson Louisa I.,
Dawson Brittany,
Salloway Stephen,
Lee Athene KW.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1340
Subject(s) - anxiety , medicine , tolerability , suicidal ideation , depression (economics) , apolipoprotein e , clinical trial , psychiatry , disease , clinical psychology , poison control , injury prevention , adverse effect , environmental health , economics , macroeconomics